AstraZeneca and Daiichi Sankyo’s cancer drug Enhertu bolstered outcomes for patients with early-stage breast cancer, results that could extend its reach to tens of thousands more people https://t.co/WJEyjoqBOa ...

The US Food and Drug Administration said it will approve the use of cancer drug leucovorin for a condition seen in some people with autism. Here's what to know https://t.co/BFOvL9Xe3e ...

What you need to know about leucovorin, the cancer drug the FDA will approve to treat autism. https://t.co/4xeuizxXVS ...

Merck won US approval for a novel version of its cancer drug Keytruda that’s faster to give, a key component of the marketing strategy for one of the world’s best-selling medicines as it nears patent expiration https://t.co/dFiRVhwOmB ...

Company Leadership & Background - Michelle Xia 在中国创办生物科技公司前，曾在美国制药公司积累经验 [1] - Michelle Xia 凭借公司股价飙升成为亿万富翁 (billionaire) [1] Drug Development & Performance - 该公司的癌症药物在去年的一次试验中表现优于全球最畅销药物 [1]

Michelle Xia gained experience at U.S. pharmaceutical firms before launching her own biotech company back home in China. In a trial last year, the firm’s cancer drug outperformed the world’s best seller–and its surging stock just made her a billionaire.https://t.co/ZoYfzamkJe https://t.co/IG0G41p8yq ...